SLPI facilitates cell migration by regulating lamellipodia/ruffles and desmosomes, in which Galectin4 plays an important role

References

• Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA. 1986;83(18):6692–6696.
   PubMed Web of Science ®Google Scholar
• Doumas S, Kolokotronis A, Stefanopoulos P. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun. 2005;73(3):1271–1274.
   PubMed Web of Science ®Google Scholar
• Ameshima S, Ishizaki T, Demura Y, et al. Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma. Cancer. 2000;89(7):1448–1456. .
   PubMed Web of Science ®Google Scholar
• Barker SD, Coolidge CJ, Kanerva A, et al. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy. J Gene Med. 2003;5(4):300–310. .
   PubMed Web of Science ®Google Scholar
• Bouchard D, Morisset D, Bourbonnais Y, et al. Proteins with whey-acidic protein motifs and cancer. Lancet Oncol. 2003;7(2):167–174. .
   Google Scholar
• Nukiwa T, Suzuki T, Fukuhara T, et al. Secretory leukocyte peptidase inhibitor and lung cancer. Cancer Sci. 2008;99(5):849–855. .
   PubMed Web of Science ®Google Scholar
• Devoogdt N, Hassanzadeh Ghassabeh G, Zhang J, et al. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci USA. 2003;100(10):5778–5782. .
   PubMed Web of Science ®Google Scholar
• Wagenblast E, Soto M, Gutiérrez-Ángel S, et al. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature. 2015;520(7547):358–362. .
   PubMed Web of Science ®Google Scholar
• Mikami Y, Fukushima A, Komiyama Y, et al. Human uterus myoma and gene expression profiling: a novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion. Cancer Lett. 2016;379(1):84–93. .
   PubMed Web of Science ®Google Scholar
• Chou RH, Wen HC, Liang WG, et al. Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides. Oncol Rep. 2012;27:238–245.
   PubMed Web of Science ®Google Scholar
• Machesky LM. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett. 2008;582(14):2102–2111.
   PubMed Web of Science ®Google Scholar
• Kawauchi T. Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci. 2012;13(4):4564–4590.
   PubMed Web of Science ®Google Scholar
• Cavey M, Lecuit T. Molecular bases of cell-cell junctions stability and dynamics. Cold Spring Harb Perspect Biol. 2009;1(5):a002998.
   PubMed Web of Science ®Google Scholar
• Green KJ, Getsios S, Troyanovsky S, et al. Intercellular junction assembly, dynamics, and homeostasis. Cold Spring Harb Perspect Biol. 2010;2(2):a000125. .
   PubMed Web of Science ®Google Scholar
• Takamura T, Suguro H, Mikami Y, et al. Comparison of gene expression profiles of gingival carcinoma Ca9-22 cells and colorectal adenocarcinoma HT-29 cells to identify potentially important mediators of SLPI-induced cell migration. J Oral Sci. 2017;59(2):279–287. .
   PubMed Web of Science ®Google Scholar
• Alekhina O, Burstein E, Billadeau DD. Cellular functions of WASP family proteins at a glance. J Cell Sci. 2017;130(14):2235–2241.
   PubMed Web of Science ®Google Scholar
• Brooke MA, Nitoiu D, Kelsell DP. Cell-cell connectivity: desmosomes and disease. J Pathol. 2012;226:158–171.
   PubMed Web of Science ®Google Scholar
• Huflejt ME, Leffler H. Galectin-4 in normal tissues and cancer. Glycoconj J. 2004;20(4):247–255.
   PubMed Web of Science ®Google Scholar
• Belo AI, van der Sar AM, Tefsen B, et al. Galectin-4 reduces migration and metastasis formation of pancreatic cancer cells. PLoS One. 2013;8(6):e65957. .
   PubMed Web of Science ®Google Scholar
• Maftouh M, Belo AI, Avan A, et al. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/beta-catenin signalling in pancreatic adenocarcinoma. Oncotarget. 2014;5(14):5335–5349. .
   PubMedGoogle Scholar
• Wu MM, Li CF, Lin LF, et al. Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma. Oncotarget. 2017;8(14):23787–23802. .
   PubMedGoogle Scholar
• Kozin SV, Maimon N, Wang R, et al. Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers. Oncotarget. 2017;8(65):108292–108302. .
   PubMedGoogle Scholar
• Teh MT, Gemenetzidis E, Patel D, et al. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma. PLoS One. 2012;7(3):e34329. .
   PubMed Web of Science ®Google Scholar